As of September 29, 2026, Bone Biologics's top three insider holders are Don Hankey (Chairman Of The Board, 9.37K shares), Jeff Frelick (Chief Executive Officer, 3 shares), Deina H Walsh (Chief Financial Officer, 2 shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Don Hankey | Chairman Of The Board | 0 | 9,367 | 9,367 | 99.9% | 19 Oct, 2021 |
| 2 | Jeff Frelick | Chief Executive Officer | 3 | 0 | 3 | 0.0% | 12 Sep, 2023 |
| 3 | Deina H Walsh | Chief Financial Officer | 3 | 0 | 3 | 0.0% | 14 Sep, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 08 Jan, 2026 | Jeff Frelick | Chief Executive Officer | Acquired A | 16,668 | $0.00 | $0 | 16,668 | Direct |
| 08 Jan, 2026 | Deina H Walsh | Chief Financial Officer | Acquired A | 8,335 | $0.00 | $0 | 8,335 | Direct |
| 04 Jun, 2025 | Siddhesh Rajendra Angle | Director | Acquired A | 62,894 | $0.00 | $0 | 2 | Direct |
| 04 Jun, 2025 | Bruce Stroever | Director | Acquired A | 62,894 | $0.00 | $0 | 2 | Direct |
| 04 Jun, 2025 | Phillip Terry Ii Meikle | Director | Acquired A | 62,894 | $0.00 | $0 | 2 | Direct |
| 04 Jun, 2025 | Robert E. Gagnon | Director | Acquired A | 62,894 | $0.00 | $0 | 2 | Direct |
| 15 Jan, 2025 | Jeff Frelick | Chief Executive Officer | Acquired A | 54,110 | $0.00 | $0 | 2 | Direct |
| 15 Jan, 2025 | Deina H Walsh | Chief Financial Officer | Acquired A | 27,055 | $0.00 | $0 | 1 | Direct |
| 16 Oct, 2024 | Phillip Terry Ii Meikle | Director | Acquired A | 9 | $0.00 | $0 | 0 | Direct |
| 16 Oct, 2024 | Phillip Terry Ii Meikle | Director | Acquired A | 28,185 | $0.00 | $0 | 1 | Direct |
| 17 Sep, 2024 | Robert E. Gagnon | Director | Acquired A | 30,713 | $0.00 | $0 | 1 | Direct |
| 17 Sep, 2024 | Siddhesh Rajendra Angle | Director | Acquired A | 30,713 | $0.00 | $0 | 1 | Direct |
| 17 Sep, 2024 | Bruce Stroever | Director | Acquired A | 30,713 | $0.00 | $0 | 1 | Direct |
| 17 Jan, 2024 | Jeff Frelick | Chief Executive Officer | Acquired A | 25,000 | $0.00 | $0 | 1 | Direct |
| 17 Jan, 2024 | Deina H Walsh | Chief Financial Officer | Acquired A | 12,500 | $0.00 | $0 | 0 | Direct |
| 08 Jan, 2024 | Robert E. Gagnon | Director | Acquired A | 9 | $0.00 | $0 | 0 | Direct |
| 08 Jan, 2024 | Robert E. Gagnon | Director | Acquired A | 8 | $0.00 | $0 | 0 | Direct |
| 18 Sep, 2023 | Siddhesh Rajendra Angle | Director | Acquired A | 85,763 | $0.00 | $0 | 14 | Direct |
| 18 Sep, 2023 | Bruce Stroever | Director | Acquired A | 85,763 | $0.00 | $0 | 14 | Direct |
| 18 Sep, 2023 | Erick Lucera | Director | Acquired A | 85,763 | $0.00 | $0 | 14 | Direct |